Skip to main content

Advertisement

Log in

Is the plasma endocan level a reliable predictor for the severity of erectile dysfunction?

  • Urology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

The aim of our study was to assess the correlation between serum endocan level and erectile dysfunction (ED).

Methods

A total of 92 patients were reviewed in this study after institutional review board approval. The patients’ characteristics were recorded, including age, body mass index, blood pressure, smoking history, serum creatinine, glucose, lipid profile, total testosterone, and Beck Depression Inventory scores. ED was evaluated with the Sexual Health Inventory for Men (SHIM) questionnaire and classified as severe, moderate, or mild. Scores of > 18 indicate normal erectile function and were recruited for the control group.

Results

Sixty-three patients with a median age of 56 years in the ED group and 29 patients with a median age of 55 years in the control group were compared. ED was classified as severe in 20, moderate in 25, and mild in 18 patients. A significant difference was determined between the severe ED group and the control group for serum endocan levels (p < 0.001). A significant negative correlation between the SHIM score and endocan levels (rho − 0.65; p < 0.01), age and SHIM score (rho − 0.32; p = 0.04), BMI and SHIM score (rho − 0.25; p = 0.03), and BMI and total testosterone (rho − 0.16; p = 0.04) was determined upon Spearman’s correlation analysis. A positive correlation was also determined between total testosterone and SHIM score (rho 0.50; p = 0.04). Patients’ age (p = 0.037) and serum endocan level (p = 0.029) were determined as significant in the multivariate analysis.

Conclusion

This study demonstrated the presence of an association between plasma endocan levels and ED. Endocan may be used as a new diagnostic marker for the severity of ED.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Pohjantahti-Maaroos H, Palomaki A, Hartikainen J (2011) Erectile dysfunction, physical activity and metabolic syndrome: differences in markers of atherosclerosis. BMC Cardiovasc Disord 11:36–44

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. Smith LJ, Mulhall JP, Deveci S, Monaghan N, Reid MC (2007) Sex after seventy: a pilot study of sexual function in older persons. J Sex Med 4(5):1247–1253

    Article  PubMed  Google Scholar 

  3. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB (1994) Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 151(1):54–61

    Article  PubMed  CAS  Google Scholar 

  4. Ayta IA, McKinlay JB, Krane RJ (1999) The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 84(1):50–56

    Article  PubMed  CAS  Google Scholar 

  5. Elzanaty S, Rezanezhad B, Willenheimer R, Borgquist R (2016) Association between erectile function and biomarkers of subclinical atherosclerosis: a study based on middle-aged healty men from the general population. Curr Urol 9(3):119–123

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Afsar B, Takir M, Kostek O, Covic A, Kanbay M (2014) Endocan: a new molecule playing a role in the development of hypertension and chronic kidney disease. J Clin Hypertens 16(12):914–916

    Article  Google Scholar 

  7. Yang J, Yang Q, Yu S, Zhang X (2015) Endocan: a new marker for cancer and a target for cancer therapy. Biomed Rep 3(3):279–283

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Aitkenhead M, Wang SJ, Nakatsu MN, Mestas J, Heard C, Hughes CC (2002) Identification of endothelial cell genes expressed in an in vitro model of angiogenesis: induction of ESM-1, (beta) ig-h3, and NrCAM. Microvasc Res 63(2):159–171

    Article  PubMed  CAS  Google Scholar 

  9. Arslan B, Onuk O, Hazar I, Aydin M, Cilesiz NC, Eroglu A et al (2017) Prognostic value of endocan in prostate cancer: clinicopathologic association between serum endocan levels and biochemical recurrence after radical prostatectmy. Tumori 103(2):204–208

    Article  PubMed  Google Scholar 

  10. Scherpereel A, Depontieu F, Grigoriu B, Cavestri B, Tsicopoulos A, Gentina T et al (2006) Endocan, a new endothelial marker in human sepsis. Crit Care Med 34(2):532–537

    Article  PubMed  CAS  Google Scholar 

  11. Roumeguere T, Van Antwerpen P, Fathi H, Rousseau A, Vanhamme L, Franck T et al (2017) Relationship between oxidative stres and erectile function. Free Radic Res 51(11–12):924–931

    Article  PubMed  CAS  Google Scholar 

  12. Nguyen HMT, Gabrielson AT, Hellstrom WJG (2017) Erectile dysfunction in young men-a review of the prevalence and risk factors. Sex Med Rev 5(4):508–520

    Article  PubMed  Google Scholar 

  13. Sarrazin S, Adam E, Lyon M, Depontieu F, Motte V, Landolfi C et al (2006) Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer. Biochim Biophys Acta 1765(1):25–37

    PubMed  CAS  Google Scholar 

  14. Balta S, Mikhailidis DP, Demirkol S, Ozturk C, Kurtoglu E, Demir M et al (2014) Endocan-a novel inflammatory indicator in newly diagnosed patients with hypertension:a pilot study. Angiology 65(9):773–777

    Article  PubMed  CAS  Google Scholar 

  15. Kose M, Emet S, Akpinar TS, Kocaaga M, Çakmak R, Akarsu M et al (2014) Serum endocan level and the severity of coronary artery disease: a pilot study. Angiology 66(8):727–731

    Article  PubMed  CAS  Google Scholar 

  16. Karabakan M, Bozkurt A, Akdemir S, Gunay M, Keskin E (2017) Significance of serum endothelial cell specific molecule-1 (Endocan) level in patients with erectile dysfunction: a pilot study. Int J Impot Res 29(4):175–178

    Article  PubMed  CAS  Google Scholar 

  17. Akarsu M, Atalay HA, Canat L, Ozcan M, Arman Y, Aydın S et al (2018) Endocan is markedly overexpressed in severe erectile dysfunction. Andrologia. https://doi.org/10.1111/and.12912

    Article  PubMed  Google Scholar 

  18. Komarova YA, Mehta D, Malik AB (2007) Dual regulation of endothelial junctional permeability. Sci STKE 412:re8

    Google Scholar 

  19. Finigan JH, Dudek SM, Singleton PA, Chiang ET, Jacobson JR, Camp SM et al (2005) Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation. J Biol Chem 280(17):17286–17293

    Article  PubMed  CAS  Google Scholar 

  20. McLaughlin JN, Shen L, Holinstat M, Brooks JD, Dibenedetto E, Hamm HE (2005) Functional selectivity of G protein signaling by agonist peptides and thrombin fort he protease-activated receptor-1. J Biol Chem 280(26):25048–25059

    Article  PubMed  CAS  Google Scholar 

  21. Lee W, Ku SK, Kim SW, Bae JS (2014) Endocan elicits severe vascular inflammatory responses in vitro and vivo. J Cell Physiol 229(5):620–630

    Article  PubMed  CAS  Google Scholar 

  22. Regieli JJ, Jukema JW, Doevendans PA, Zwinderman AH, Kastelein JJ, Grobbee DE et al (2009) Paraoxonase variants relate to 10-year risk in coronary artery disease: impact of a high-density lipoprotein-bound antioxidant in secondary prevention. J Am Coll Cardiol 54(14):1238–1245

    Article  PubMed  CAS  Google Scholar 

  23. Menon P, Kocher ON, Aird WC (2011) Endothelial cell specific molecule-1 (ESM-1), a novel secreted proteoglycan stimulates vascular smooth muscle cell proliferation and migration. Circulation 124:A15455

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Burak Arslan.

Ethics declarations

Conflict of interest

All the authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Onuk, Ö., Arslan, B., Gezmis, T.C. et al. Is the plasma endocan level a reliable predictor for the severity of erectile dysfunction?. Int Urol Nephrol 50, 1577–1582 (2018). https://doi.org/10.1007/s11255-018-1946-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-018-1946-2

Keywords

Navigation